Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 22Active not recruiting 9Recruiting 8Unknown 3Terminated 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 3Breast Neoplasms 2Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Pulmonary Disease, Chronic Obstructive 1Prostate Adenocarcinoma 1Pain 1Overweight 1Obesity 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Arthralgia 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 77Capecitabine 59Cyclophosphamide 54Paclitaxel 51Docetaxel 49Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 25exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Everolimus 17Taxes 16Epirubicin 15Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13pertuzumab 12palbociclib 12liposomal doxorubicin 11Magnetic Resonance Spectroscopy 11Filgrastim 11Cisplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Educational Status × Clear all
NCT05452681 2026-05-07

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

University of Alabama at Birmingham

Phase NA Terminated
27 enrolled
Breast

Breast Neoplasms

NCT01351844 2017-08-30

CEASE

George Washington University

Phase NA Terminated
12 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡